placeholder image

R. A. Soo All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 

    • Contact

    full name

  • R. A. Soo

    • Quick Info

    Publications

    Collaboration